Top compounds associated with response to ANKRD20A4


Feature Type Standardized
Nominal ANOVA
mRNA myriocin CTRPv2 pan-cancer AAC -0.096 0.3
mRNA bid1870 gCSI pan-cancer AAC 0.059 0.3
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA MS-275 gCSI pan-cancer AAC 0.056 0.3
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC -0.082 0.3
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.035 0.3
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.04 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA MS-275 CTRPv2 pan-cancer AAC 0.034 0.3
Download CSV